It is important to note that B-ALL with the RCSD1-ABL1 fusion has recently been included into a specific molecular subtype of high-risk B-ALL, known as Philadelphia- (Ph-) like ALL, which is characterized by an expression signature resembling that of Philadelphia-positive ALL [12]. Here, RCSD1 is linked to precursor B-cell acute lymphoblastic leukemia.